Cannabis Testing Market Projected to Reach $3.2 Billion by 2030

LOS ANGELES- The global cannabis testing market is projected to experience significant growth, with estimates indicating an increase from $1.26 billion in 2025 to $2.33 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.12%.

This expansion is driven by the increasing legalization of cannabis for medical and recreational use, necessitating rigorous testing for safety and potency. The complexity of multi-state and evolving pesticide regulations presents both challenges and opportunities for testing laboratories to ensure compliance and maintain product quality.​

North America is anticipated to maintain the largest market share during this period, attributed to the region’s progressive cannabis policies and established testing infrastructure. Concurrently, the Asia Pacific region is expected to exhibit the fastest growth, spurred by emerging legalization efforts and heightened awareness of cannabis applications.

Market segmentation indicates that potency testing services will continue to dominate due to the critical need for accurate cannabinoid profiling. End-users such as cannabis cultivators, drug manufacturers, and research institutions are projected to drive demand for comprehensive testing services.​

The evolving regulatory landscape, particularly concerning pesticide usage, underscores the necessity for adaptable and robust testing protocols. Laboratories that can navigate these complexities are well-positioned to capitalize on the market’s growth trajectory. source​